Hepatology
Commentary
How a cheap liver drug may be the key to preventing COVID
The authors of a paper appearing in Nature give us multiple, complementary lines of evidence.
Clinical Inquiries
How accurate is transcutaneous bilirubin testing in newborns with darker skin tones?
EVIDENCE-BASED ANSWER: Fairly accurate. Photometric transcutaneous bilirubin (TcB) testing may overestimate total serum bilirubin (TSB) in...
Conference Coverage
Midodrine may be comparable to albumin for PICD prevention in ACLF
Given the small size of the open-label study, with only 25 patients in each arm, the results should be considered as proof of concept and need to...
Conference Coverage
Bepirovirsen: Is a ‘functional cure’ for HBV on the horizon?
“Bepirovirsen is just one RNA-based HBV therapy now being pursued. Several other antisense RNAs as well as the more malleable small interfering...
Conference Coverage
Liver disease-related deaths rise during pandemic
“The increasing trend in mortality rates for ALD and NAFLD has been quite alarming, with disparities in age, race, and ethnicity.”
Conference Coverage
World falls short on HBV, HCV elimination targets
“As countries progress toward eliminating hepatitis B and C, we really need to do more to expand political will and financing of national...
Conference Coverage
Noninvasive tests may provide prognostic value in NAFLD
Fibrosis biomarkers were significantly predictive of event-free survival probability.
Conference Coverage
Low-carb diet aids weight loss in liver transplant recipients with obesity
The diet didn’t negatively affect serum lipids or renal function.
Guidelines
New AGA guidelines advise use of antiobesity medications for weight management
Though lifestyle interventions are the first-line treatment for overweight and obesity, use of specific pharmacological agents should be...
From the Journals
Mentorship key to improving GI, hepatology workforce diversity
A collaboration of five gastroenterology and hepatology medical organizations presented findings on workforce perspectives on diversity and how to...
News
FDA okays terlipressin (Terlivaz) injection for hepatorenal syndrome
The synthetic vasopressin analog is an injectable medication indicated for patients with hepatorenal syndrome experiencing rapid deterioration of...